A new White House report was spurred by several incidents involving safety lapses in infectious disease research at federal facilities. It is the result of a "safety stand-down" announced a year ago to inventory potentially dangerous pathogens, and to review the impact of current rules on select agents. The University of Hawaii Office of Research Compliance participated in a stakeholder listening session, submitting testimony. The review also included input from experts and the public.
The second report is an internal review conducted by the Centers for Disease Control and Prevention (CDC) of its select agents and toxins division. It was prompted by a series of incidents at Federal Select Agent Program facilities, including the transfer of live samples of disease-causing viruses from CDC to other laboratories. The review recommends improvements in inspections, incident reporting, and transparency.